New blood marker could speed up diagnosis of deadly gut condition
NCT ID NCT03671928
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether a substance called glicentin in the blood can help diagnose intestinal ischemia, a condition where blood flow to the gut is blocked. Researchers measured glicentin levels in 54 people with suspected ischemia and compared them to a control group. The goal is to find a better, faster way to diagnose this serious condition, which currently has poor diagnostic tools.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a new blood test to diagnose intestinal ischemia faster and more accurately, potentially saving lives.
- What could go wrong
- This is a small, early-stage study with only 54 participants. The results may not be strong enough to create a reliable test, and the findings need confirmation in larger trials.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ISCHEMIA BOWEL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Nice Hospital
Nice, 06000, France